DiaMedica Therapeutics Inc. (DMAC) income statement
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.59+0.21 (+2.51%)
Close on Nov 18, 2026Market cap $463.22MP/E –Yield –
DiaMedica Therapeutics Inc. financial ratios
See a number that looks wrong?